Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:pasireotide
|
| gptkbp:approvalYear |
2012
|
| gptkbp:approvedBy |
gptkb:European_Union
gptkb:United_States |
| gptkbp:ATCCode |
H01CB05
|
| gptkbp:brand |
gptkb:Signifor
|
| gptkbp:chemicalClass |
peptide
|
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Signifor
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
somatostatin receptor agonist
|
| gptkbp:pregnancyCategory |
Not recommended
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
gptkb:diabetes_mellitus
hyperglycemia gastrointestinal disorders cholelithiasis |
| gptkbp:usedFor |
gptkb:Cushing's_disease
acromegaly |
| gptkbp:bfsParent |
gptkb:NOVN
|
| gptkbp:bfsLayer |
5
|